Scutellaria baicalensis Inhibits Coxsackievirus B3-Induced Myocarditis Via AKT and p38 Pathways
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Scutellaria baicalensis Georgi has been widely used in China for treatment of various diseases. This study investigated the effect of Scutellaria baicalensis Georgi extracts (SBE) against Coxsackievirus B3 (CVB3)-induced myocarditis in vitro and in vivo. In vitro, Hela cells and primary myocardial cells were infected with CVB3 and treated with SBE (50-800 μg/ml) and ribavirin (200 μM) for 48 h and then determined by CCK8 assay. Real-time PCR and western blotting assays were performed. In vivo, a myocarditis model was induced in male BALB/c mice by injecting CVB3 suspension intraperitoneally for three times, followed by treatment with SBE (400 and 200 mg/kg) and ribavirin (100 mg/kg) for 28 days. SBE ameliorated the cytotoxicity of CVB3 in Hela cells, especially at 400 μg/ml (39.93% vs 65.67%, p < 0.05) without influencing cell growth and also significantly reduced CVB3 replication in primary myocardial cells. The levels of AKT, ERK, and p38 were increased after CVB3 infection. SBE could downregulate the expressions of AKT and p38. In vivo, the mortality rate from CVB3 reached to 66.67%, while 10.00% and 23.33% of this came after 400 and 200 mg/kg SBE treatment, respectively (p < 0.05). The CVB3 replication was obviously reduced after SBE administration from day 5. Similarly, the levels of AKT, ERK, and p38 mRNAs and proteins were increased, and SBE suppressed the expression of AKT and p38. Our study indicates that SBE is a promising potent antiviral agent against CVB3-induced myocarditis by inhibition of virus replication via depressing AKT and p38 expressions.
Abstract
Scutellaria baicalensis Georgi has been widely used in China for treatment of various diseases. This study investigated the effect of Scutellaria baicalensis Georgi extracts (SBE) against Coxsackievirus B3 (CVB3)-induced myocarditis in vitro and in vivo. In vitro, Hela cells and primary myocardial cells were infected with CVB3 and treated with SBE (50-800 μg/ml) and ribavirin (200 μM) for 48 h and then determined by CCK8 assay. Real-time PCR and western blotting assays were performed. In vivo, a myocarditis model was induced in male BALB/c mice by injecting CVB3 suspension intraperitoneally for three times, followed by treatment with SBE (400 and 200 mg/kg) and ribavirin (100 mg/kg) for 28 days. SBE ameliorated the cytotoxicity of CVB3 in Hela cells, especially at 400 μg/ml (39.93% vs 65.67%, p < 0.05) without influencing cell growth and also significantly reduced CVB3 replication in primary myocardial cells. The levels of AKT, ERK, and p38 were increased after CVB3 infection. SBE could downregulate the expressions of AKT and p38. In vivo, the mortality rate from CVB3 reached to 66.67%, while 10.00% and 23.33% of this came after 400 and 200 mg/kg SBE treatment, respectively (p < 0.05). The CVB3 replication was obviously reduced after SBE administration from day 5. Similarly, the levels of AKT, ERK, and p38 mRNAs and proteins were increased, and SBE suppressed the expression of AKT and p38. Our study indicates that SBE is a promising potent antiviral agent against CVB3-induced myocarditis by inhibition of virus replication via depressing AKT and p38 expressions.
참고문헌 (28)
- Sagar S, "Myocarditis", Lancet, 379, pp.738~747 (2012)
- Pollack A, "Viral myocarditis-diagnosis, treatment options, and current controversies", Nat. Rev. Cardiol, 12, pp.670~680 (2015)
- Howlett SE, "Coxsackievirus B3-induced myocarditis : new insights into a female advantage", Can. J. Cardiol, 34, pp.354~355 (2018)
- Rose NR, "Learning from myocarditis : mimicry, chaos and black holes", F1000Prime Rep, 6, pp.25~ (2014)
- Chang H, "The PI3K", Akt, Int. J. Mol. Med, pp.2017, 40[DOI]
- Wen J, "Coxsackieviruses B3 infection of myocardial microvascular endothelial cells activates fractalkine via the ERK1", 2 signaling pathway, 2017, pp.16, 7548~7552
- Jiang S, "Activation of AMP-activated protein kinase reduces collagen production via p38 MAPK in cardiac fibroblasts induced by coxsackievirus B3", Mol. Med. Rep, 14, pp.989~994 (2016)
- Zhao Q, "Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plants", Sci. Bull, 61, pp.1391~1398 (2016)
- Li Q, "FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1alpha", CEACAM5 functional axis, 2018, pp.14, 726~735
- Hussain I, "Scutellaria baicalensis targets the hypoxia-inducible factor1alpha and enhances cisplatin efficacy in ovarian cancer", J. Cell Biochem, 119, pp.7515~7524 (2018)
- Kwon BE, "Antiviral activity of oroxylin A against Coxsackievirus B3 alleviates virus-induced acute pancreatic damage in mice", PLoS One, 11, pp.e0155784~ (2016)
- Jiang Y, "Oxymatrine provides protection against Coxsackievirus B3induced myocarditis in BALB", c mice, 2017, pp.141, 133~139
- Zandi K, "Extract of Scutellaria baicalensis inhibits dengue virus replication", BMC Complement. Altern. Med, 13, pp.91~ (2013)
- Ji S, "AntiH1N1 virus, cytotoxic and Nrf2 activation activities of chemical constituents from Scutellaria baicalensis", J. Ethnopharmacol, 76, pp.475~484 (2015)
- Lin H, "Efficacy of Scutellaria baicalensis for the treatment of hand, foot, and mouth disease associated with Encephalitis in patients infected with EV71 : a multicenter, retrospective analysis", Biomed. Res. Int, 2016, pp.5697571~ (2016)
- Ma Q, "Comparative study on the antivirus activity of ShuangHuang-Lian injectable powder and its bioactive compound mixture against human adenovirus III in vitro", Viruses, 9(4), pp.79~ (2017)
- Ma Q, "San Wu Huangqin Decoction, a Chinese herbal formula, inhibits influenza a", PR, 34(H1N1)virus infection in vitro and in vivo, pp.Viruses, 2018[DOI]
- Garmaroudi FS, "Coxsackievirus B3 replication and pathogenesis", Future Microbiol, 10, pp.629~653 (2015)
- 이윤경, "Fructus Amomi Cardamomi Extract Inhibits Coxsackievirus-B3 Induced Myocarditis in a Murine Myocarditis Model", Journal of Microbiology and Biotechnology, 26(11), pp.2012~2018 (2016), 한국미생물·생명공학회
- Dai Q, "Berberine restricts coxsackievirus B type 3 replication via inhibition of c-Jun N-terminal kinase(JNK)and p38 MAPK activation in vitro", Med. Sci. Monit, 23, pp.1448~1455 (2017)
- Chen Y, "Inhibition mechanisms of baicalin and its phospholipid complex against DHAV-1 replication", Poult. Sci, 97, pp.3816~3825 (2018)
- Chen Y, "Antiviral effect of baicalin phospholipid complex against duck hepatitis A virus type 1", Poult. Sci, 97, pp.2722~2732 (2018)
- Kang S, "Baicalin effects on rats with spinal cord injury by anti-inflammatory and regulating the serum metabolic disorder", J. Cell Biochem, 119, pp.7767~7779 (2018)
- Acta virologicaWu Y, "Baicalin alleviates atherosclerosis by relieving oxidative stress and inflammatory responses via inactivating the NF-kappaB and p38 MAPK signaling pathways", Biomed. Pharmacother, 97, pp.1673~1679 (2018)
- You J, "Baicalin, a Chinese herbal medicine, inhibits the proliferation and migration of human non-small cell lung carcinoma(NSCLC)cells, A549 and H1299, by activating the SIRT1", AMPK signaling pathway, 2018, pp.24, 2126~2133
- Wang Z, "Baicalin induces cellular senescence in human colon cancer cells via upregulation of DEPP and the activation of Ras", Raf, ERK signaling, pp.Cell Death Dis, 2018[DOI]
- Seong RK, "Wogonin, a flavonoid isolated from Scutellaria baicalensis, has anti-viral activities against influenza infection via modulation of AMPK pathways", Acta Virol, 62, pp.78~85 (2018)
- Zhang Y, "Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter", Biomed. Pharmacother, 102, pp.1003~1014 (2018)